Human immunodeficiency virus and the peripheral nervous system workshop

Archives of Neurology

Volumn 58, Issue 10, 2001, Pages 1561-1566

  Brinley Jr , F J ^a   Pardo, Carlos A ^b   Verma, Ashok ^c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; GABAPENTIN; MEXILETINE; NARCOTIC ANALGESIC AGENT; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SODIUM CHANNEL BLOCKING AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL MODEL; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NONHUMAN; PAIN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY; WORKSHOP;

EID: 0034793567     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.10.1561     Document Type: Conference Paper

References (4)

1. HIV-associated neuropathies: Role of HIV-1, CMV, and other viruses
2. Epidemiology and clinical features of HIV-1 associated neuropathies
3. Peripheral neuropathy and retroviral drugs
4. HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease